The stock market has inched its way to one record high after another this year, with the S&P 500 gaining a solid if unspectacular 3.5 percent so far. That rise has enriched investors by some $900 billion in 2015, as Matt Krantz at USA Today points out.
As Krantz also notes, though, some shareholders have done far, far better than the broader market. Jeff Bezos, for example.
The Amazon CEO has benefitted from a 40 percent rise in his company’s stock in 2015, adding a whopping $9.5 billion in paper gains to his already sizable net worth to lift it to $38.2 billion, good enough for 11th highest in the world, according to Bloomberg’s Billionaires Index.
As well as Bezos has done, four foreign billionaires have actually made more in 2015: Pan Sutong, chairman of Hong Kong investment conglomerate Goldin Group, has made more than $20 billion; Wang Jianlin, the founder and chairman of another Chinese conglomerate, Dalian Wanda, has made $19.4 billion; Zhou Qunfei, China’s richest woman, has added nearly $11 billion; and Patrick Drahi, the French chairman and largest shareholder of Luxembourg-based telecom company Altice, has gained $9.7 billion.
Bezos may be far ahead of the U.S. pack, but the USA Today analysis of data from S&P Capital IQ shows some other CEOs of American companies have fared extremely well as a result of their stock holdings, too. Facebook’s Mark Zuckerberg has made more than $1 billion on paper, while Google’s Larry Page has gained just under $1 billion. And as shares of drugstore chain Walgreens Boots Alliance have surged more than 11 percent this year, acting CEO Stefano Pessina has profited to the tune of $645.6 million. The CEOs of salesforce.com, Under Armour, Starbucks, Mohawk Industries, Constellation Brands and Netflix have all seen paper gains of more than $260 million so far in 2015.
You can see USA Today’s full list here.
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
From Gallup: “A record 25% of Americans say they or a family member put off treatment for a serious medical condition in the past year because of the cost, up from 19% a year ago and the highest in Gallup's trend. Another 8% said they or a family member put off treatment for a less serious condition, bringing the total percentage of households delaying care due to costs to 33%, tying the high from 2014.”
That’s how much the private debt collection program at the IRS collected in the 2019 fiscal year. In the black for the second year in a row, the program cleared nearly $148 million after commissions and administrative costs.
The controversial program, which empowers private firms to go after delinquent taxpayers, began in 2004 and ran for five years before the IRS ended it following a review. It was restarted in 2015 and ran at a loss for the next two years.
Senate Finance Chairman Chuck Grassley (R-IA), who played a central role in establishing the program, said Monday that the net proceeds are currently being used to hire 200 special compliance personnel at the IRS.
The federal budget deficit for October and November was $342 billion, up $36 billion or 12% from the same period last year, the Congressional Budget Office estimated on Monday. Revenues were up 3% while outlays rose by 6%, CBO said.